FDA Inspection 1006385 — Quintiles Beograd D.O.O

Quintiles Beograd D.O.O — FEI 3007725657

The FDA completed an inspection of Quintiles Beograd D.O.O on Mar 2, 2017 in Belgrade. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 2, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Belgrade (Serbia)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.